Premium
Clinicopathological characteristics, outcomes and pattern of mutations in patients with follicular lymphoma who progressed on Bruton tyrosine kinase inhibitors
Author(s) -
Jain Preetesh,
KanagalShamanna Rashmi,
San Lucas F. Anthony,
Nastoupil Loretta,
Romaguera Jorge,
Fayad Luis,
Oki Yasuhiro,
Westin Jason R.,
Medeiros Leonard Jeffrey,
Wang Michael,
Fowler Nathan
Publication year - 2018
Publication title -
british journal of haematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.907
H-Index - 186
eISSN - 1365-2141
pISSN - 0007-1048
DOI - 10.1111/bjh.14857
Subject(s) - ibrutinib , bruton's tyrosine kinase , discontinuation , medicine , oncology , chronic lymphocytic leukemia , follicular lymphoma , cancer research , tyrosine kinase , lymphoma , leukemia , receptor
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom